Champions Oncology Inc (STU:2I3)
€ 4 0.1 (2.56%) Market Cap: 55.93 Mil Enterprise Value: 59.94 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 72/100

Q1 2020 Champions Oncology Inc Earnings Call Transcript

Sep 16, 2019 / NTS GMT
Operator

Good day, ladies and gentlemen, and welcome to your Champions Oncology first quarter fiscal year 2020 earnings conference call. (Operator Instructions) At this time, it is my pleasure to turn the floor over to the CEO, Dr. Ronnie Morris. Sir, the floor is yours.

Ronnie Morris
Champions Oncology, Inc. - CEO

Good afternoon. Joining me today is David Miller, our Chief Financial Officer. Thank you for joining us for our quarterly earnings call. Before I begin, I'll remind you that I will be making forward-looking statements during today's call, and that actual results could differ materially from what is described in those statements. Additional information on factors that could cause results a difference are available in our Form 10-Q and Form 10-K.A reconciliation of non-GAAP financial measures that may be discussed during the call to GAAP financial measures is available in earnings release.

I will start by pointing out that our prepared comments for today will be relatively brief as we just recently provided our fiscal 2019 year-end results and company

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot